XML 21 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities    
Net loss $ (70,858) $ (89,940)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of property and equipment 539 443
Amortization of platform development and intangible assets 26,570 24,731
Amortization of debt costs 1,581 2,106
Loss on impairment of assets 466 1,192
Loss on impairment of lease 466
Loss on termination of lease 7,345
Change in valuation of warrant derivative liabilities (34)
Liquidated damages 1,140 2,637
Gain upon debt extinguishment (5,717)
Accrued and noncash converted interest 320 6,956
Stock-based compensation 31,345 30,493
Deferred income taxes (1,200) (1,674)
Bad debt expense 658 499
Other 184
Change in operating assets and liabilities net of effect of acquisitions:    
Accounts receivable (2,038) (3,884)
Subscription acquisition costs (1,667) 3,108
Royalty fees 11,250 15,000
Prepayments and other current assets 2,280 49
Other long-term assets (285) 692
Accounts payable (6,535) 3,752
Accrued expenses and other (2,996) 7,474
Unearned revenue 3,898 (15,819)
Subscription refund liability (2,379) (949)
Operating lease liabilities (218) (2,489)
Other long-term liabilities (3,359) (1,166)
Net cash used in operating activities (11,304) (14,729)
Cash flows from investing activities    
Purchases of property and equipment (530) (377)
Capitalized platform development (5,179) (4,819)
Proceeds from sale of equity investment 2,450
Payments for acquisitions, net of cash (35,331) (7,950)
Net cash used in investing activities (38,590) (13,146)
Cash flows from financing activities    
Proceeds from bridge notes, net of debt costs 34,728
Proceeds from long-term debt 5,086
Payments of long-term debt (5,928)
Proceeds, net of repayments, under line of credit 2,104 4,809
Proceeds from common stock public offering, net of offering costs 32,058
Payments of issuance costs from common stock public offering (1,568)
Proceeds from common stock private placement 20,005
Payments of issuance costs from common stock private placement (167)
Proceeds from exercise of common stock options 95
Payment of deferred cash payment (453)
Payment for taxes related to common stock withheld for taxes (4,468) (70)
Payment of restricted stock liabilities (2,152) (1,472)
Net cash provided by financing activities 54,416 28,191
Net increase in cash, cash equivalents, and restricted cash 4,522 316
Cash, cash equivalents, and restricted cash – beginning of year 9,851 9,535
Cash, cash equivalents, and restricted cash – end of year 14,373 9,851
Cash, cash equivalents, and restricted cash    
Cash and cash equivalents 13,871 9,349
Restricted cash 502 502
Total cash, cash equivalents, and restricted cash 14,373 9,851
Supplemental disclosure of cash flow information    
Cash paid for interest 9,528 1,393
Cash paid for income taxes
Noncash investing and financing activities    
Reclassification of stock-based compensation to platform development 1,884 2,045
Issuance of common stock in connection with professional services 125
Restricted stock issued in connection with an acquisition 502
Debt costs recorded in accrued expenses and other and in other long-term liabilities 441 509
Reclassification of warrants to equity 1,113
Issuance of common stock in connection with settlement of liquidated damages 7,008
Issuance of common stock in connection with an acquisition 3,141
Deferred cash payments recorded in connection with acquisitions 628 1,324
Assumption of liabilities in connection with acquisitions $ 17,100 $ 85